Skip to main content

Login to My NLA Account

Search form

To enhance the science and practice of lipidology and promote optimal cardiometabolic health.

Join the NLA

Home
About Us
new_about

Overview

History and Mission

Leadership

Staff

Committees and Councils

Industry Council

Chapters

Bylaws and Policies

Honors & Awards
Stay
Recommendations & Statements
Practice Tools
new_practice

Resources

Patient and Clinician Tear Sheets

Access to Therapy

Operations Resources

Work Groups

Job Opportunities

Other Lipidology Resources
Stay
Conferences & Education
new_meetings

Conferences

Ancillary Courses

Attendee Resources

Attendee Resources

Attendee Resources

Educational Links

Abstracts

Lipid Library

Certifications

NLA-SAP

CLM-SAP

Submit a Proposal

Meeting Highlights

Claim CME
LDL-C LIMBO Activity Series
Stay
Membership
new_membership

Becoming an NLA Member

Trainee Membership

Member Benefits

Mentoring Program
Stay
Communications
new_communications

NLA Initiatives

NLA News

News Releases

Past Meeting Coverage

Sign up for email updates

Publications

Podcasts
Stay
Foundation
Contact Us

Sign-In
About Us
Practice Tools
Conferences & Education
Communications
Membership
Foundation
Contact Us
Search
Recommendations & Statements

Challenges in Prescribing PCSK9 Inhibitors

Publish Date:

Friday, January 6, 2017 - 13:45

This page was last updated: Feb 02, 2017

About Us
Resources
Conferences & Education
Communications
Membership

National Lipid Association • c/o Compass Management & Consulting, Inc. • 12574 Flagler Center Blvd, Suite 101 • Jacksonville, FL 32258 • 904-998-0854
© 2025 National Lipid Association, All Rights Reserved • Terms of Use • Privacy Policy

Login to your NLA Account

Username *

Password *

Request new password